Reply: Sodium-Glucose Cotransporter 2 Inhibitor Use and Outcomes in Transthyretin Amyloid Cardiomyopathy
Related Posts
Cho PD, White JP, Kim ST, Zappacosta H, McKay S, Kim HJ, Abramov A, Daniel M, Biniwale R, Sayah D, Gjertson D, Ardehali A. Early[...]
Zong NC, Huang K, Yang X, Cai H. Expand the success of screening to reduce aortic aneurysm mortality: progress interpretation and new fronts. Trends Cardiovasc[...]
Scapin G, Cillis JL, Goulard MC, Patch TC, Gomez Limia CE, Ding Y, Du W, Dharampuriya PR, Hagedorn EJ, Anderson H, Musso GA, Curley CR,[...]